To investigate the functional roles of CDK12 in trastuzumab-resistant breast cancer progression, we knocked down CDK12 via two independent siRNAs in JIMT1 and BT474-Tr cells (Fig. 5A, B). Here, CDK12 is linked to breast carcinoma.